LINCO-SPECTIN PREMIX ANTIBIOTIC FOR SWINE

Pays: Australie

Langue: anglais

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Ingrédients actifs:

LINCOMYCIN AS LINCOMYCIN HYDROCHLORIDE; SPECTINOMYCIN AS SPECTINOMYCIN SULFATE

Disponible depuis:

ZOETIS AUSTRALIA PTY LTD

DCI (Dénomination commune internationale):

lincomycin as HCl(22g/kg)+spectinomycin as sulfate(22g/kg)

forme pharmaceutique:

ORAL POWDER, PRE-MIX

Composition:

LINCOMYCIN AS LINCOMYCIN HYDROCHLORIDE ANTIBIOTIC Active 22.0 g/kg; SPECTINOMYCIN AS SPECTINOMYCIN SULFATE ANTIBIOTIC Active 22.0 g/kg

Unités en paquet:

20kg; 5kg

classe:

VM - Veterinary Medicine

Fabriqué par:

ZOETIS AUSTRALIA

Groupe thérapeutique:

PIGS | BOAR | GILT | PIGLET | SOW | SWINE

Domaine thérapeutique:

NUTRITION & METABOLISM

indications thérapeutiques:

BLOODY SCOURS | ENTERITIS ASSOCIATED WITH E.COLI | MYCOPLASMAL PNEUMONIA | PROMOTE ANIMAL GROWTH | SALMONELLOSIS | VIBRIONIC DYSENTERY | FEED CONVERSION | FINISHING | GROWTH PROMOTION | GROWTH RATE | LIVEWEIGHT GAIN | SWINE DYSENTERY

Descriptif du produit:

Poison schedule: 4; Withholding period: WHP: MEAT: Do not use less than 1 day before slaughter for human consumption. TRADE ADVICE: EXPORT SLAUGHTER INTERVA L (ESI): This product does not have and ESI established.; Host/pest details: PIGS: [BLOODY SCOURS, ENTERITIS ASSOCIATED WITH E.COLI, MYCOPLASMAL PNEUMONIA, SALMONELLOSIS, VIBRIONIC DYSENTERY]; For the treatment and control of swine dysentery; salmonellosis; enteritis associated with E. coli and as an aid in control of mycoplasmal pneumonia.DO NOT continue medication beyond the period prescribed by the veterinarian.

Statut de autorisation:

Registered

Date de l'autorisation:

2023-07-01

Notice patient

LINCO-SPECTIN PREMIX ANTIBIOTIC FOR SWINE
38701/109777
Product Name:
APVMA Approval No:
Label Name:
LINCO-SPECTIN PREMIX ANTIBIOTIC FOR SWINE
Signal Headings:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
22 g/kg LINCOMYCIN AS LINCOMYCIN HYDROCHLORIDE
22 g/kg SPECTINOMYCIN AS SPECTINOMYCIN SULFATE
Claims:
For the treatment and control of swine dysentery (vibrionic dysentery,
bloody scours);
salmonellosis (necrotic enteritis); enteritis associated with E. Coli
and as an aid in control of
mycoplasmal pneumonia.
Net Contents:
20kg
5kg
Directions for Use:
Restraints:
Restraints
DO NOT continue medication beyond the period prescribed by the
veterinarian.
Precautions:
Precautions
For use in pigs only. Do not allow rabbits, hamsters, guinea pigs,
horses or ruminants
access to feed containing lincomycin. Ingestion by these species may
result in severe
gastrointestinal effects.
Lincomycin should not be used in animals known to be hypersensitive to
the product.
Do not use the water treatment and the feed treatment simultaneously.
Side Effects:
Side effects
Excessive dosage may lead to an increased incidence of side effects
which may include
rectal prolapse.
Occasionally, swine treated with lincomycin, within the first two days
after the onset of
treatment, may develop diarrhoea and/or swelling of the anus. On rare
occasions, some RLP APPROVED
pigs may show reddening of the skin and irritable behaviour. These
conditions have been
self-correcting within 5 to 8 days without discontinuing lincomycin
treatment.
Dosage and
Administration:
For treatment and control of the diseases specified, complete feeds
containing 44 grams of
antibiotic activity per tonne should be fed.
General Directions:
Mixing Directions:
LINCO-SPECTIN® Premix must be mixed thoroughly in feeds before use.
For making Medicated Complete Feeds;
Add 1 kg LINCO-SPECTIN® Premix per tonne of complete feed to give 44g
of antibiotic
activity per tonne.
Medicated feed should constitute the sole ration of

Résumé des caractéristiques du produit

PRODUCT NAME: LINCO-SPECTIN
® PREMIX ANTIBIOTIC FOR SWINE
PAGE: 1 OF 5
THIS REVISION ISSUED: APRIL, 2010
MATERIAL SAFETY DATA SHEET
Issued by: Pfizer Australia Pty Ltd
Phone: [phone]
SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
Pfizer Australia Pty Ltd
38-42 Wharf Road
West Ryde NSW 2114
Tel: [phone]
Fax: [phone]
____________________________________
PFIZER AUSTRALIA PTY LTD
A.B.N. 50 008 422 348
SUBSTANCE:
Active ingredients are antibiotics.
TRADE NAME:
LINCO-SPECTIN
® PREMIX ANTIBIOTIC FOR SWINE
PFIZER MSDS CODE:
MSDS 090
PRODUCT USE:
Antibiotic.
CREATION DATE:
JANUARY, 2005
REVISION DATE:
APRIL, 2010
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of NOHSC
Australia.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
Not Hazardous - No criteria found.
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good.
UN NUMBER:
None allocated
E
E
E
M
M
M
E
E
E
R
R
R
G
G
G
E
E
E
N
N
N
C
C
C
Y
Y
Y
O
O
O
V
V
V
E
E
E
R
R
R
V
V
V
I
I
I
E
E
E
W
W
W
PHYSICAL DESCRIPTION & COLOUR
: Tan coloured powder.
ODOUR:
No data.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
P
P
P
O
O
O
T
T
T
E
E
E
N
N
N
T
T
T
I
I
I
A
A
A
L
L
L
H
H
H
E
E
E
A
A
A
L
L
L
T
T
T
H
H
H
E
E
E
F
F
F
F
F
F
E
E
E
C
C
C
T
T
T
S
S
S
Repeated overexposure to lincomycin may cause abdominal cramps,
diarrhoea and colitis. This may begin several
weeks after exposure has ceased. Some hematopoietic effects have been
reported with the use of lincomycin.
Hypersensitivity reactions have been reported in people known to be
sensitive to penicillin. Rare instances of
erythema multiforme, some resembling Stevens-Johnsone Syndrome, have
been associated with lincomycin
hydrochloride.
INHALATION
SHORT TERM EXPOSURE:
Significant inhalation exposure is considered to be unlikely. Long
term inhalation